Abeona Therapeutics Newsroom

Abeona Therapeutics Analyst Ratings

BenzingaNov 25 07:47 ET

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsNov 25 07:31 ET

Positive Outlook for Abeona Therapeutics: FDA Acceptance and Strategic Initiatives Reinforce Buy Rating

TipRanksNov 25 07:00 ET

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsOct 31 06:31 ET

Abeona Therapeutics Analyst Ratings

BenzingaOct 29 11:49 ET

Abeona Therapeutics Price Target Maintained With a $18.00/Share by Cantor Fitzgerald

Dow JonesSep 20 11:19 ET

Stifel Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsAug 15 08:31 ET

Analysts Conflicted on These Healthcare Names: Abeona Therapeutics (ABEO), Cyclacel Pharmaceuticals (CYCC) and Cardinal Health (CAH)

TipRanksAug 15 08:24 ET

Abeona Therapeutics Analyst Ratings

BenzingaAug 14 07:32 ET

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $15

Moomoo NewsAug 14 07:31 ET

Buy Rating on Abeona Therapeutics Bolstered by Positive Medicare Decisions and FDA Approval Progress

TipRanksAug 14 06:44 ET

Stifel Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsAug 13 06:35 ET

Abeona Therapeutics Analyst Ratings

BenzingaJul 12 06:10 ET

HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $15 Price Target

BenzingaJul 12 06:10 ET

Stifel Nicolaus Sticks to Its Buy Rating for Abeona Therapeutics (ABEO)

TipRanksJul 9 07:37 ET

Abeona Therapeutics Analyst Ratings

BenzingaJul 3 06:18 ET

Abeona Therapeutics Analyst Ratings

BenzingaMay 30 08:08 ET

Abeona Therapeutics Analyst Ratings

BenzingaMay 16 11:21 ET

Abeona Therapeutics Analyst Ratings

BenzingaApr 23 08:48 ET

Abeona Therapeutics Analyst Ratings

BenzingaAug 24, 2023 11:49 ET